This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

If you are not a UK healthcare professional, visit our COVID-19 page for the public.

Information for UK Healthcare Professionals about COVID-19

COVID-19 is an extraordinary challenge to the global community. In the face of this unprecedented challenge, we would like to extend our sincere appreciation to all those who are going above and beyond to do their part in helping affected patients and communities, especially the NHS, healthcare workers and volunteers who are on the front-line of this fight.

As a company dedicated to saving and improving lives, MSD recognises that we have a special responsibility to help. MSD remains focused on protecting the safety of its employees and their families, assuring the supply and manufacture of medicines and vaccines for our patients and populations, contributing our scientific expertise to the development of antiviral approaches, and supporting our healthcare providers and the communities in which they serve.

We know many of you have questions and we want to answer them as best as we can. To help you navigate your questions, we’re providing the list of FAQs below:

COVID-19 and Vaccines

Is there any guidance available on continuing routine immunisation services during the new coronavirus pandemic?
Will MSD vaccine supply be impacted as a result of the current coronavirus outbreak?
Is there any guidance available as to the timing of administration of an MSD manufactured vaccine before or after an episode of the COVID-19?
How should the administration of vaccinations against pneumococcal disease be prioritised?

COVID-19 and HIV

Does MSD have medicines and/or vaccines for COVID-19? If not, is MSD developing any medicines and/or vaccines to help combat COVID-19?
Do antibiotics work against the new coronavirus?
What treatment options are available against the new coronavirus?
Information for Persons Living with HIV (PLWH) and COVID-19
Are any of MSD’s HIV medicines being investigated for their activity against the COVID-19 virus?
How can we stay up to date on COVID-19?

COVID-19 and Oncology

If a patient on pembrolizumab contracts SARS-CoV-2, does MSD have any recommendations on the best course of action?
Is there any information on whether cancer patients treated with pembrolizumab have an increased risk of SARS-CoV-2 infection?
Is there any information on the impact of SARS-CoV-2/COVID-19 on pembrolizumab in patients with lung cancer?
Are there any pembrolizumab alternatives/less resource-intensive treatment dosing regimens?
Can MSD provide any methods to educate, monitor and review patients on pembrolizumab to minimise patient exposure/hospital attendance?
For how long can pembrolizumab be stopped?
Is MSD offering any home-infusion services for pembrolizumab patients?
Pembrolizumab: COVID-19 and immune-mediated pneumonitis
Is there any information on the interactions between pembrolizumab and any of the options that are being considered/used for the treatment of COVID-19?

COVID-19 and Cardiology/Renal

Should patients continue to take Angiotensin Receptor Blockers (ARB), during the COVID-19 pandemic?